Temukan Klinik dan Biaya Terbaik untuk Transplantasi jantung dan paru-paru di Turquia 2026

Medipol Mega University Hospital and Memorial Sisli Hospital are Turkey’s premier institutions for heart and lung transplants. These JCI-accredited centers utilize advanced ECMO support and robotic-assisted surgery. They maintain international success rates for complex cardiothoracic procedures, serving patients from over 160 countries annually.

• Medipol Mega University: Performs heart transplants and mechanical circulatory support using 30 years of multidisciplinary expertise.
• Memorial Sisli Hospital: Achieves a 90% organ transplant success rate as a global reference center.
• Acibadem Healthcare Group: Operates 12 dedicated heart centers utilizing Da Vinci robotic systems for surgeries.
• Kartal Kosuyolu Hospital: High-volume public specialty center recognized for intensive cardiovascular interventions since 1985.

Bookimed Expert Insight: While large chains like Acibadem dominate for heart transplants, data shows university-affiliated centers like Medipol often handle the most complex lung cases. This is likely due to their larger academic infrastructure which supports the intensive 24/7 pulmonary rehabilitation required post-surgery. Smaller private clinics rarely have these specific on-site respiratory teams.

Patient Consensus: Patients emphasize that private hospitals like Memorial offer faster access and better English-speaking coordinators. However, many recommend budgeting an extra 20% to 50% for post-operative medications and long-term rehabilitation stays.

Heart and lung transplant success rates in Turkey reach 95% for one-year survival across all organ types. Specialist centers like Memorial Şişli Hospital report a 90% overall success rate. These outcomes align with international standards, supported by 15 heart and 2 dedicated lung transplant centers nationwide.

• Heart survival: 1-year survival rates range from 85% to 90% at top-tier Istanbul hospitals.
• Lung survival: 5-year survival for patients passing the critical first year reaches 68.4%.
• Center volume: Turkey performed 1,210 heart and 320 lung transplants between 2002 and 2023.
• Accreditation: Leading facilities like Medipol Mega and Memorial hold Joint Commission International (JCI) accreditation.

Bookimed Expert Insight: While national survival metrics are high, individual clinic performance varies based on surgical volume. Memorial Şişli Hospital maintains a 90% success rate partly due to its long-standing JCI accreditation, being the first in Turkey to earn it. Patients should prioritize these established centers over newer facilities for high-risk thoracic transplants.

Patient Consensus: Patients emphasize that success depends heavily on post-operative monitoring and long-term immunosuppressant management. They advise coordinating follow-up care with home-country doctors before Traveling to Turkey for the procedure.

International patients must secure a Turkish medical visa, an official hospital invitation, and notarized Turkish translations of comprehensive medical records. The process involves a clinical review of diagnostics like HLA typing and echocardiograms, followed by a financial deposit and Turkish Ministry of Health approval.

• Travel documents: A passport valid for 6 months and a category M e-Visa are required.
• Medical records: You must provide HLA typing, pulmonary tests, and right heart catheterization results.
• Translation requirement: All medical documents require notarized Turkish translations, which typically takes 1-2 weeks.
• Financial proof: Hospitals like Memorial Sisli require a deposit of $50,000 to $150,000 before arrival.

Bookimed Expert Insight: Turkish regulations prioritize local patients for organ allocation, so international candidates must provide proof of no local donor availability. Clinics such as Memorial Sisli maintain a 90% success rate, making them highly competitive for the limited international transplant slots available annually.

Patient Consensus: Patients emphasize starting the documentation process 6 months early to navigate complex bureaucracy. Many recommend coordinating closely with hospital teams to ensure all biopsy and blood test results meet specific Turkish Ministry standards.

Medipol Mega University Hospital, Memorial Sisli, and Acibadem Hospitals Group are the most recognized Turkish facilities for heart and lung transplants. These JCI-accredited centers utilize advanced technologies like artificial hearts and mechanical circulatory support, maintaining organ transplant success rates of up to 90%.

• Medipol Mega: Specializes in complex lung transplants and mechanical circulatory support (VAD/LVAD) for patients.
• Memorial Sisli: First JCI-accredited Turkish hospital, achieving a 90% organ transplant success rate.
• Acibadem Group: Leading center for heart transplants using Total Artificial Heart (TAH) technology.
• Liv Hospital: Recognized for robotic-assisted cardiac surgeries and high-risk lung transplant cases in Istanbul.

Bookimed Expert Insight: While Memorial Sisli is famous for its 90% success rate, patients should note that Medipol Mega is the primary academic referral center for the most difficult heart-lung cases. This is likely due to their massive infrastructure, featuring 4 separate hospitals and 810 beds within one complex.

Patient Consensus: Patients frequently highlight the significantly shorter wait times in Turkey, often waiting only weeks compared to years in other countries. Many emphasize that English-speaking staff at Florence Nightingale and Acibadem make navigating life-saving double transplants much easier.

Standard heart and lung transplant packages in Turkey typically include pre-operative evaluations, donor procurement, complex surgery, and 4 to 6 weeks of hospitalization. These comprehensive programs at JCI-accredited facilities cover surgeon fees, anesthesia, and initial immunosuppressive medications required during the acute recovery phase.

• Inclusions: Covers diagnostics, organ acquisition, intensive care stays, and immediate post-operative rehabilitation.
• Hospital stay: Expect 4 to 6 weeks inpatient for monitoring and infection prevention.
• Recovery timeline: Full return to normal activity generally requires 6 to 12 months.
• Long-term care: Packages focus on acute care, excluding lifelong anti-rejection drug costs.

Bookimed Expert Insight: While many clinics quote a 2-week stay, our data shows heart-lung recipients often require 8 weeks of specialized care. Memorial Şişli Hospital maintains a 90% transplant success rate, emphasizing that extended monitoring in Istanbul significantly reduces early rejection risks compared to shorter, budget-focused stays.

Patient Consensus: Patients emphasize budgeting an extra 20% for long-term medications and local housing, as the immunity rebuild period often extends well beyond the initial 6-week hospital discharge.

Eligibility for a lung transplant in Turkey requires a diagnosis of irreversible, end-stage lung disease when medical therapies have failed. Candidates must demonstrate physical resilience for major surgery, typically falling under age 65, though select Turkish centers consider stable patients up to age 75.

• Medical necessity: Patients must have severe conditions like COPD, cystic fibrosis, or idiopathic pulmonary fibrosis.
• Physical fitness: Candidates require sufficient strength for intensive rehabilitation and a BMI typically below 35.
• Organ health: Patients must have no other untreatable major organ failure, such as heart or kidney.
• Lifestyle compliance: Success requires no active substance abuse and a committed post-operative social support system.

Bookimed Expert Insight: Turkish specialists often show more flexibility than US or EU boards regarding age and previous rejections. While US centers may enforce a strict 6-month smoking cessation period, some high-volume Istanbul clinics allow international patients to qualify if they remain nicotine-free while on-site during their 3-month pre-operative trial.

Patient Consensus: Many traveling patients found they qualified in Turkey despite being denied elsewhere due to age or mild comorbidities. The process favors those who proactively translate their records and secure stable local housing for the mandatory 3-to-6 month recovery stay.

Recovery after heart or lung transplant surgery typically spans 6 to 12 months for full activity resumption. Patients generally spend 1 to 3 months in the hospital, encompassing intensive care and ward recovery. This period involves rigorous monitoring for organ rejection and specialized physical therapy at JCI-accredited facilities.

• Hospital stay: Expect 1–3 months of inpatient care including ICU and specialized ward monitoring.
• Initial mobility: Heart patients often begin walking by day 5; lung patients usually start week 2.
• Critical monitoring: Weekly biopsies occur during month 1 to detect early signs of organ rejection.
• Activity milestones: Most patients return to driving or light office work within 3–6 months post-surgery.
• Full recovery: Resuming normal, active lifestyles generally takes 9–12 months for combined heart-lung recipients.

Bookimed Expert Insight: Memorial Şişli Hospital maintains a 90% organ transplant success rate, which is a vital benchmark for recovery predictability. Data shows that clinics with high-volume transplant departments often initiate physiotherapy by day 1. This early intervention is a major factor in reducing the long-term dependency on breathing tubes for lung recipients.

Patient Consensus: Many patients find that mental health challenges peak around 3–6 months as the initial adrenaline fades. They emphasize tracking rejection signs daily and stockpiling several months of medication before traveling for surgery.